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A 54-year-old man, with no cardiovascular risk 
factors, was admitted with 2-hour chest pain. Five 
days earlier, he had been found to be coronavirus 
disease 2019 (COVID-19) positive, but his clinical 
condition had allowed him to be managed at home.
On admission, the patient was hemodynami-
cally stable, afebrile, with no respiratory symp-
toms. His electrocardiogram was consistent with 
ST-segment elevation myocardial infarction. His 
complete blood count, international normalized 
ratio, activated partial thromboplastin time, and 
C-reactive protein were normal. D-dimer was 
4400 μg/L, ferritin was 914 μg/L and high sensitiv-
ity troponin I > 50000 ng/L. Neither pulmonary 
embolism nor COVID-19 features was detected 
on computed tomography. 
Coronary angiography revealed an acute occlu-
sion of the proximal left anterior descending artery 
(LAD) (Fig. 1A) and non-occlusive thrombus in the 
proximal right coronary artery (RCA). The latter 
artery was occluded in the second and the third 
posterolateral branches (Fig. 1B, C). The flow in 
the LAD was restored with a drug-eluting stent 
(Fig. 1D, E). An attempt to retrieve the RCA thrombi 
with a thrombectomy catheter was unsuccessful 
(Fig. 1F) and a decision was made to treat the patient 
with a bolus and 18-hour infusion of eptifibatide and 
dual antiplatelet therapy (acetylsalicylic acid plus 
ticagrelor). The patient was transferred to our dedi-
cated COVID-19 ward in stable condition. Further 
in-hospital stay was uneventful.
The presented case was unique as there was 
a lack of either cardiovascular factors or respiratory 
symptoms. Previous cases of COVID-19 patients 
have mainly reported on multivessel coronary 
thrombosis in the context of severe pneumonia 
or multiorgan failure. The present case implies 
a unique hypercoagulable state associated with 
COVID-19 irrespective of cardiovascular risk fac-
tors and lung involvement. 
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Figure 1. A. Acute occlusion of the left anterior descending artery (LAD; arrow); B. Thrombus (white arrow) in the 
proximal segment of the right coronary artery (RCA) and occlusion of the second (black arrow) and the third postero-
lateral branch (RPL; red arrow); C. Thrombus burden in the second and the third RPL (white arrows); D, E. Postpro-
cedural left coronary angiography; F. Post-procedural right coronary angiography.
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